Understanding immune responses to improve vaccines and treatments for diseases.

NIH Tetramer Core Facility for Immunologic and Infectious Disease

NIH-funded research Emory University · NIH-11171231

This study is all about helping scientists learn more about how our immune system fights infections and diseases, which could lead to better vaccines and treatments that might help you and others stay healthier in the future.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionEmory University NIH-funded
Lab location1 site (Atlanta, United States)
Project IDNIH-11171231 on NIH RePORTER

What this research studies

This research focuses on enhancing our understanding of how the immune system responds to infections and diseases. It supports the development of vaccines and new therapies by providing essential resources, such as MHC tetramer reagents, to researchers worldwide. Patients may benefit indirectly as this work aims to lead to better prevention and treatment options for infectious and immune-mediated diseases. The research involves collaboration with various biomedical researchers to advance public health.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include individuals affected by infectious or immune-mediated diseases who may eventually receive improved treatments.

Not a fit: Patients with conditions unrelated to infectious or immune-mediated diseases may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccines and therapies for infectious diseases, enhancing patient care and outcomes.

How similar studies have performed: Previous research in immunology and vaccine development has shown significant success, indicating that this approach is promising and builds on established methodologies.

Where this research is happening

Atlanta, United States

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.